Overall Technical outlook

Price Summary

On 2026-06-03, Aurobindo Pharma Limited's stock began at 1432.5, climbed to 1458.0, dropped to 1419.2, and had 0.55% to end at 1440.4, with a volume of 969120 shares.
In the 52-week period, the stock's peak price is 1546.7, and the lowest price recorded is 1022.2.

Technicals

Support and Resistance: The price of 1440.4 is supported at 1435.4 and capped by resistance at 1487.3. These levels mark key points for Aurobindo Pharma Limited where the price could find stability, with 1435.4 as a floor and 1487.3 as a ceiling.
AUROPHARMA supportResistance dde5fc
Support/Resistance for AUROPHARMA


Aroon: The current reading of the AROON is neutral for AUROPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AUROPHARMA aroon dde5fc
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
AUROPHARMA bbands dde5fc
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR for AUROPHARMA continues to signal a bearish stance, reinforcing a resistance level that could restrict upward movement. This resistance suggests that the market may remain under bearish pressure, with limited potential for breaking higher.
AUROPHARMA psar dde5fc
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The K-line has moved above the D-line on the stochastic indicator for AUROPHARMA, even as it stays below 20, often considered the start of a bullish move. This suggests that the market might be in the early stages of a recovery, leading to potential gains. Investors may see this as an indication of rising momentum.
AUROPHARMA stoch dde5fc
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are currently aligned bearishly, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are beginning to waver, indicating that this bearish momentum might be fading. This could suggest an upcoming shift towards bullish price action, as the market's current downward trend may be approaching a reversal, potentially leading to a new upward move.
AUROPHARMA trippleSMA dde5fc
Tripple SMA chart for Aurobindo Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.